Robert E Claypoole sold $262k of BVS
President and CEO at Bioventus Inc.. 28,786 shares at an average of $9.10, traded Jan 13, 2025, filed Jan 14, 2025.
Score components
- +25RoleCEO
- +13Trade size$262k at market
- +10Share of holdings soldSold 31% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +17.5%, 3m -12.7%, 6m -25.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001578563-25-000023, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 13, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -28,786 | $9.10 | $262k | 64,964 | Jan 14, 2025 |
Related signals
Other insiders at Bioventus Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | BVSsell Bioventus Inc. | Michelle McMurry-Heath director | $105k 12,000 shares | -21% | |
| 23Weak | BVSsell Bioventus Inc. | Guy P Nohra director | $76k 10,000 shares | -8% | |
| 31Weak | BVSsell Bioventus Inc. | Michelle McMurry-Heath director | $131k 17,701 shares | -24% | |
| 10Weak | Bioventus Inc. | Church Katrina J SVP & Chief Compliance Officer | $9,712 1,283 shares | -2% | |
| 10Weak | Bioventus Inc. | Anthony D'Adamio SVP & General Counsel | $22k 2,958 shares | -2% | |
| 22Weak | Bioventus Inc. | Mark Leonard Singleton SVP & CFO | $29k 3,875 shares | -3% | |
| 24Weak | Bioventus Inc. | Mark Leonard Singleton SVP & CFO | $54k 5,479 shares | -4% | |
| 15Weak | Bioventus Inc. | Anthony D'Adamio SVP & General Counsel | $25k 2,615 shares | -2% | |
| 10Weak | Bioventus Inc. | Church Katrina J SVP & Chief Compliance Officer | $9,926 1,018 shares | -2% | |
| 10Weak | Bioventus Inc. | Church Katrina J SVP & Chief Compliance Officer | $16k 1,537 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.